CYB5R1
Basic information
Region (hg38): 1:202961873-202967275
Previous symbols: [ "NQO3A2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYB5R1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 0 | 0 |
Variants in CYB5R1
This is a list of pathogenic ClinVar variants found in the CYB5R1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-202962561-A-C | not specified | Uncertain significance (Sep 26, 2022) | ||
1-202962598-T-C | not specified | Uncertain significance (Nov 27, 2023) | ||
1-202962630-T-G | not specified | Uncertain significance (Nov 13, 2024) | ||
1-202962650-G-T | not specified | Uncertain significance (Sep 02, 2024) | ||
1-202962651-T-C | not specified | Uncertain significance (Mar 07, 2024) | ||
1-202962667-C-T | not specified | Uncertain significance (Mar 24, 2023) | ||
1-202963116-C-T | not specified | Uncertain significance (Mar 23, 2022) | ||
1-202963117-G-A | not specified | Uncertain significance (Mar 29, 2022) | ||
1-202963144-G-A | not specified | Uncertain significance (Jun 18, 2021) | ||
1-202963161-T-C | not specified | Uncertain significance (Dec 13, 2021) | ||
1-202963665-A-G | not specified | Uncertain significance (Apr 07, 2023) | ||
1-202963701-G-A | not specified | Uncertain significance (Sep 30, 2024) | ||
1-202963722-T-C | not specified | Uncertain significance (Aug 12, 2021) | ||
1-202964644-G-A | not specified | Uncertain significance (Oct 01, 2024) | ||
1-202965406-C-T | not specified | Uncertain significance (May 28, 2024) | ||
1-202965499-A-G | not specified | Uncertain significance (Jan 23, 2023) | ||
1-202965906-T-C | not specified | Uncertain significance (Nov 25, 2024) | ||
1-202965984-A-G | not specified | Uncertain significance (Jun 18, 2021) | ||
1-202966580-C-G | not specified | Uncertain significance (Jun 07, 2024) | ||
1-202966587-T-G | not specified | Uncertain significance (Feb 07, 2023) | ||
1-202966850-C-T | not specified | Uncertain significance (Apr 16, 2024) | ||
1-202966865-G-C | not specified | Uncertain significance (Aug 17, 2022) | ||
1-202966895-G-A | not specified | Uncertain significance (Jun 22, 2021) | ||
1-202967201-C-T | not specified | Uncertain significance (Sep 05, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYB5R1 | protein_coding | protein_coding | ENST00000367249 | 9 | 5412 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.36e-9 | 0.206 | 125690 | 0 | 58 | 125748 | 0.000231 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.510 | 155 | 174 | 0.891 | 0.00000945 | 1944 |
Missense in Polyphen | 64 | 75.374 | 0.8491 | 864 | ||
Synonymous | -0.696 | 77 | 69.6 | 1.11 | 0.00000351 | 644 |
Loss of Function | 0.470 | 14 | 16.0 | 0.873 | 9.23e-7 | 173 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000540 | 0.000539 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.000231 | 0.000231 |
European (Non-Finnish) | 0.000264 | 0.000246 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000367 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: NADH-cytochrome b5 reductases are involved in desaturation and elongation of fatty acids, cholesterol biosynthesis, drug metabolism, and, in erythrocyte, methemoglobin reduction. {ECO:0000250}.;
- Pathway
- Amino sugar and nucleotide sugar metabolism - Homo sapiens (human);Oxidation by Cytochrome P450;O2/CO2 exchange in erythrocytes;Transport of small molecules;Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis;Erythrocytes take up carbon dioxide and release oxygen
(Consensus)
Recessive Scores
- pRec
- 0.130
Intolerance Scores
- loftool
- 0.367
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.57
Haploinsufficiency Scores
- pHI
- 0.352
- hipred
- N
- hipred_score
- 0.282
- ghis
- 0.554
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.975
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cyb5r1
- Phenotype
Gene ontology
- Biological process
- platelet degranulation;bicarbonate transport;sterol biosynthetic process;oxidation-reduction process
- Cellular component
- mitochondrion;endoplasmic reticulum membrane;plasma membrane;membrane;integral component of membrane;platelet alpha granule membrane;extracellular exosome
- Molecular function
- cytochrome-b5 reductase activity, acting on NAD(P)H;protein binding;FAD binding